FDA-Inspected Site

GlaxoSmithKline Biologicals SA

5 FDA inspections are on record for GlaxoSmithKline Biologicals SA in Wavre, Belgium.

483· Form 483 issued

Wavre, Belgium · Last updated July 10, 2026

Overview

  • 5 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-02-27.

At a glance

Inspections

5

Form 483s

2

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
9 Feb 2026 – 27 Feb 2026Biologics483View 483 →
5 Jun 2023 – 23 Jun 2023BiologicsClean
7 Oct 2019 – 11 Oct 2019BiologicsClean
3 Jun 2019 – 24 Jun 2019Biologics483On file
11 Apr 2003Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

27 Feb 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Shafiq Ahadi, Thai D Truong

27 Feb 2026
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Shafiq Ahadi, Thai D Truong

27 Feb 2026
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Shafiq Ahadi, Thai D Truong

27 Feb 2026
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Shafiq Ahadi, Thai D Truong

27 Feb 2026
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Shafiq Ahadi, Thai D Truong

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind GlaxoSmithKline Biologicals SA's 2 Form 483s

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat